Improving psychiatric drug benefit management: I. Lessons from Massachusetts

Psychiatric Services

Volumn 54, Issue 7, 2003, Pages 949-951

  Sabin, James E ^a,b   Daniels, Norman ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Dept of Ambulatory Care/Prevention ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT;

DRUG COST; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; MANAGED CARE; MEDICAID; MENTAL DISEASE; PHARMACY; PSYCHOPHARMACOTHERAPY; REVIEW; UNITED STATES; ARTICLE; ECONOMICS; HEALTH INSURANCE; LEGAL ASPECT;

HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MANAGED CARE PROGRAMS; MASSACHUSETTS; MEDICAID; MENTAL DISORDERS; PSYCHOTROPIC DRUGS;

EID: 0038110732     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.7.949     Document Type: Review

References (9)

1. Sabin JE: The realities of today's formularies. Psychiatric News 38(7):34, 2003
2. Daniels N, Teagarden JR, Sabin JE: An ethical template for pharmacy benefits. Health Affairs 22(1):125-137, 2003
3. Daniels N, Sabin JE: Setting Limits Fairly. New York, Oxford University Press, 2002
4. Bernasek C, Farkas J, Felman H, et al: Case Study: Michigan's Medicaid Prescription Drug Benefit. Washington, DC, Henry J Kaiser Family Foundation, Jan 2003. Available at www.kff.org/content/2003/4083/4083.pdf
5. Duckworth K, Hanson A: Using a clinical and evidence-based strategy to preserve access to psychiatric medications. Psychiatric Services 53:1231-1232, 2002
6. Mulligan K: DB partners with state to develop drug formulary. Psychiatric News 38 (10):12, 2003
7. Ellison J: Letter to Massachusetts Psychiatric Society members. Wellesley Hills, Mass, Massachusetts Psychiatric Society, Apr 18, 2003
8. Therapeutic Class Table 24: Atypical Antipsychotics, Boston, Massachusetts Division of Medical Assistance. Available at www. state.ma.us/dma/providers/pharmacy/thera putic/mh_table-24.htm
9. Massachusetts Psychiatric Society. Formulary Developments: Position Statement. Wellesley, Mass, Massachusetts Psychiatric Society. Available at www.psychiatry-mps. org/legislative_alerts.shtml